Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01030003 · ClinicalTrials.gov registry record
Snoring in Pregnancy and Adverse Maternal and Fetal Outcomes
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 1,685
- Enrollment target
NCT01030003: Completed study, sponsored by University of Michigan.
NCT01030003 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 1,685 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01030003 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 1,685 participants
- Enrollment target
Study Summary
The purpose of the study is to determine the prevalence of sleep-disordered breathing in pregnant women during the third trimester of pregnancy and to investigate whether this is associated with high blood pressure in the mother and/or growth retardation in the baby.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,685 participants |
| Start Date | 2007-01 |
| Est. Completion | 2011-08 |
What the finished NCT01030003 record still lists
NCT01030003 is an observational study that tracks outcomes without assigning an intervention. Its 1,685 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01030003 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01030003 about?
NCT01030003 is a clinical study titled "Snoring in Pregnancy and Adverse Maternal and Fetal Outcomes". The purpose of the study is to determine the prevalence of sleep-disordered breathing in pregnant women during the third trimester of pregnancy and to investigate whether this is associated with high blood pressure in the mother and/or growth retardation in the baby.
What is the current status of trial NCT01030003?
This trial is currently completed. The enrollment target is 1,685 participants. The study started on 2007-01. Estimated completion is 2011-08.
Who is sponsoring clinical trial NCT01030003?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06376565 · 1,680 participants · NA
Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps
- NCT04321200 · 1,700 participants
PANDA Gym: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability
- NCT06238622 · 1,700 participants · Phase 3
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
- NCT07284901 · 1,700 participants · Phase 3
Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia